SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Solara Active Pharma Sciences informs about integrated filing

29 Jan 2025 Evaluate
Pursuant to SEBI Circular No. SEBI/HO/CFD/CFD-PoD-2/CIR/P/2024/185 dated December 31, 2024, NSE Circular No. NSE/CML/2025/02 dated January 02, 2025, and BSE Circular No. 20250102-4 dated January 02, 2025, Solara Active Pharma Sciences has submitted the Integrated Filing (Financials) for quarter and nine months ended December 31, 2024. The same will also be hosted on the Company's website: www.solara.co.in.

The above information is a part of company’s filings submitted to BSE.

Solara Active Pharma Share Price

493.70 0.00 (0.00%)
15-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1702.60
Dr. Reddys Lab 1225.00
Cipla 1231.90
Zydus Lifesciences 947.60
Lupin 2338.65
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×